A 3D virtual model of the PKMYT1–PROTAC–CRBN ternary complex depicting how Insilico Medicine’s bifunctional proteolysis-targeting chimera (PROTAC) D16-M1P2 (shown in…
Primary immune thrombocytopenia (ITP) is an autoimmune condition where the body’s immune cells mistakenly attack platelets, the blood cells responsible…
Mirum Pharmaceuticals signed a definitive agreement to acquire Bluejay Therapeutics, a privately-held biotech company focused on viral and liver diseases.…